The global genome editing market size is calculated at USD 10.91 billion in 2025 and is forecasted to reach around USD 43.19 billion by 2034, accelerating at a CAGR of 16.56% from 2025 to 2034. The North America genome editing market size surpassed USD 4.48 billion in 2024 and is expanding at a CAGR of 16.56% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Genome Editing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Genome Editing Market, by Technology
8.1.1. (CRISPR)/Cas9
8.1.1.1. Market Revenue and Forecast
8.1.2. ZFN
8.1.2.1. Market Revenue and Forecast
8.1.3. Meganuclease
8.1.3.1. Market Revenue and Forecast
8.1.4. TALENs/MegaTALs
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Genome Editing Market, by Delivery Method
9.1.1. Ex-vivo
9.1.1.1. Market Revenue and Forecast
9.1.2. In-vivo
9.1.2.1. Market Revenue and Forecast
10.1. Genome Editing Market, by Application
10.1.1. Genetic Engineering
10.1.1.1. Market Revenue and Forecast
10.1.2. Clinical Applications
10.1.2.1. Market Revenue and Forecast
11.1. Genome Editing Market, by Mode
11.1.1. Contract
11.1.1.1. Market Revenue and Forecast
11.1.2. In-house
11.1.2.1. Market Revenue and Forecast
12.1. Genome Editing Market, by End-use
12.1.1. Biotechnology and Pharmaceutical Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Contract Research Organizations
12.1.2.1. Market Revenue and Forecast
12.1.3. Academic and Government Research Institutes
12.1.3.1. Market Revenue and Forecast
12.1.4. OSAT
12.1.4.1. Market Revenue and Forecast
12.1.5. Others
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology
13.1.2. Market Revenue and Forecast, by Delivery Method
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by Mode
13.1.5. Market Revenue and Forecast, by End-use
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology
13.1.6.2. Market Revenue and Forecast, by Delivery Method
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by Mode
13.1.6.5. Market Revenue and Forecast, by End-use
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Technology
13.1.7.2. Market Revenue and Forecast, by Delivery Method
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by Mode
13.1.7.5. Market Revenue and Forecast, by End-use
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology
13.2.2. Market Revenue and Forecast, by Delivery Method
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by Mode
13.2.5. Market Revenue and Forecast, by End-use
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology
13.2.6.2. Market Revenue and Forecast, by Delivery Method
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by Mode
13.2.8. Market Revenue and Forecast, by End-use
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology
13.2.9.2. Market Revenue and Forecast, by Delivery Method
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by Mode
13.2.11. Market Revenue and Forecast, by End-use
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology
13.2.12.2. Market Revenue and Forecast, by Delivery Method
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by Mode
13.2.13. Market Revenue and Forecast, by End-use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology
13.2.14.2. Market Revenue and Forecast, by Delivery Method
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by Mode
13.2.15. Market Revenue and Forecast, by End-use
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology
13.3.2. Market Revenue and Forecast, by Delivery Method
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by Mode
13.3.5. Market Revenue and Forecast, by End-use
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology
13.3.6.2. Market Revenue and Forecast, by Delivery Method
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by Mode
13.3.7. Market Revenue and Forecast, by End-use
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology
13.3.8.2. Market Revenue and Forecast, by Delivery Method
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by Mode
13.3.9. Market Revenue and Forecast, by End-use
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology
13.3.10.2. Market Revenue and Forecast, by Delivery Method
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by Mode
13.3.10.5. Market Revenue and Forecast, by End-use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology
13.3.11.2. Market Revenue and Forecast, by Delivery Method
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by Mode
13.3.11.5. Market Revenue and Forecast, by End-use
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology
13.4.2. Market Revenue and Forecast, by Delivery Method
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by Mode
13.4.5. Market Revenue and Forecast, by End-use
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology
13.4.6.2. Market Revenue and Forecast, by Delivery Method
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by Mode
13.4.7. Market Revenue and Forecast, by End-use
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology
13.4.8.2. Market Revenue and Forecast, by Delivery Method
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by Mode
13.4.9. Market Revenue and Forecast, by End-use
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology
13.4.10.2. Market Revenue and Forecast, by Delivery Method
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by Mode
13.4.10.5. Market Revenue and Forecast, by End-use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology
13.4.11.2. Market Revenue and Forecast, by Delivery Method
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by Mode
13.4.11.5. Market Revenue and Forecast, by End-use
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology
13.5.2. Market Revenue and Forecast, by Delivery Method
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by Mode
13.5.5. Market Revenue and Forecast, by End-use
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology
13.5.6.2. Market Revenue and Forecast, by Delivery Method
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by Mode
13.5.7. Market Revenue and Forecast, by End-use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology
13.5.8.2. Market Revenue and Forecast, by Delivery Method
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by Mode
13.5.8.5. Market Revenue and Forecast, by End-use
14.1. Merck KGaA.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cibus Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Recombinetics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Sangamo Therapeutics
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cellectis S.A.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. AstraZeneca
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Takara Bio Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Horizon Discovery Ltd. (Revvity, Inc.)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Editas Medicine
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Precision BioSciences
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample